Kyle Shea Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 612 E Oak St, Glenwood City, WI 54013 Phone: 715-265-4325 |
News Archive
Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010.
Antares Pharma, Inc. announced today that it has completed enrollment in the double-blind portion of the Company's Phase 3 clinical trial of Anturol™, its transdermal oxybutynin ATD™ gel for the treatment of overactive bladder (OAB). Top line data from this pivotal trial, which is being conducted under a Special Protocol Assessment (SPA) from the U.S. Food and Drug Administration (FDA), is expected in the third quarter of this year.
Valeant Pharmaceuticals International, Inc. and Kadmon Pharmaceuticals LLC have concluded two strategic agreements for the development and commercialization of taribavirin and the commercial marketing of ribavirin in the treatment of viral diseases, including hepatitis C virus (HCV).
"A notable feature of Secretary of State Hillary Rodham Clinton's 'AIDS-free generation' initiative is to strengthen health care systems in sub-Saharan Africa, ... a view echoed by many eminent voices in the global health community," Anand Reddi of the University of Colorado Medical School writes in a post on Huffington Post's "Impact" blog.
After surviving acute respiratory distress syndrome, a disease in which fluid begins to leak into the lungs of critically ill patients and makes it difficult to breathe, many patients develop mental illness.
› Verified 6 days ago